Few U.S. adults diagnosed with hepatitis C virus infections receive timely treatment with antiviral drugs, the U.S. Centers for Disease Control and Prevention said on Tuesday.
https://www.pharmalive.com/wp-content/uploads/2015/06/cross-section-of-hepatitis-c-virus.png468700Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-08-09 13:53:012022-08-10 11:18:00Few U.S. patients with hepatitis C get timely treatment, CDC says
